Evidence map›Paper›PMID 37261366›Full record

ReviewFrontiers in immunology2023

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective.

Narges Ebrahimi, Zahra Yousefi, Gholamreza Khosravi, Fatemeh Eskandari Malayeri, Marjan Golabi, Monireh Askarzadeh, Mohammad Hossein Shams, Behrooz Ghezelbash, Nahid Eskandari

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06815939 (Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer), which is not on this map. Cited by 87 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 7 pooled it
24.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06815939 narecruitingnot on this mapstarted 2025, after this paper: background citation

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer: Automated Visual Evaluation

TypeinterventionalSponsorDL AnalyticsRan2025 to 2026Enrolled10,000ConditionsHuman Papillomavirus (HPV), Cervical Intraepithelial Neoplasia, Uterine Cervical Neoplasms, Cervical CancersArmsHPV Test, EVA System, Visual Inspection with Acetic Acid (VIA), Automated Visual Evaluation (AVE), Image Capture with Mobile Phone
3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 7 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Redefining oropharyngeal cancer in the HPV era: integrating precision medicine and immunotherapeutic frontiers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Narges EbrahimiImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra YousefiSchool of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
Gholamreza KhosraviImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Fatemeh Eskandari MalayeriImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Marjan GolabiImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Monireh AskarzadehImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad Hossein ShamsDepartment of Medical Immunology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Behrooz GhezelbashImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nahid EskandariImmunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IRLorestan University of Medical Sciences · IRShahroud University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However, immunization programs remain vulnerable to macroeconomic factors such as inflation, fiscal policy, employment levels, and national income. This review aims to investigate the association between national income in lower-middle-income countries to explore recent advances and potential issues, as well as how to deal with challenges.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsDeveloping CountriesFemaleHuman Papillomavirus VirusesHumansVaccinationPapillomavirus Vaccinescervical cancerhuman papilloma virus (HPV)immunization programlow-and middle-income countries (LMICs)vaccination

Identifiers

PMID37261366
PMCPMC10227716
OpenAlexW4378952305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.